Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

Cancer is one of the world’s leading causes of death. It is the third leading cause of death in the Philippines in 2023, ...

The social media platform is days away from a shutdown — and users are scrambling to find new homes for their content.

The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.

LDCT is an effective tool for detecting early-stage lung cancer and reducing mortality, and with the support of the ministry ...

Any lingering doubts over the feasibility of rolling out population-based cancer registries in low-income and middle-income countries ought to have been dispelled by the COVID-19 pandemic. Within ...

Innovent Biologics (OTCPK:IVBIY) announced that Chinese regulators have approved its second marketing application for lung cancer therapy, Dovbleron, developed with U.S. biotech Nuvation Bio ...

Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the stock to all-time highs. Read the full report on the stock here.